← Leaderboards
Bumsoo Han
University Of Texas Arlington
$5,749,366
Attributed
$14,536,220
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,536,220 · 7
By mechanism
U01$7,948,245 · 2
R01$3,352,890 · 2
R61$1,688,965 · 1
R33$1,405,210 · 1
P30$140,910 · 1
Top collaborators
- Melissa L Fishel15 shared
- Matthew J. Flick10 shared
- Martha U Gillette5 shared
- Hyunjoon Kong5 shared
- Alisa S Wolberg5 shared
Most similar at University Of Texas Arlington
Same institution · by research overlap
- Hyeok Choi$173,750
- Georgios Alexandrakis$2,027,542
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsFibroblastsTumor MicroenvironmentSignal TransductionMalignant Neoplasm Of PancreasTumorIn VivoMalignant NeoplasmsBaseDesignInnovationInsightMicrofluidicsTissuesExtracellular MatrixDrug ResistanceMediatingCessation Of LifeCoagulation ProcessBlood CoagulationBiomimeticsCancer Etiology3-DimensionalGrowth
Grant awards (30)
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$932,376
U01 · FY2025 · CA · contact PI
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid Chip$475,788
R33 · FY2025 · HL
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors$433,463
R01 · FY2025 · CA
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$885,794
U01 · FY2024 · CA · contact PI
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid Chip$449,079
R33 · FY2024 · HL
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors$411,790
R01 · FY2024 · CA
Drug Delivery and Molecular Sensing (DDMS)$28,182
P30 · FY2024 · CA · contact PI
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$670,662
U01 · FY2023 · CA · contact PI
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid Chip$480,343
R33 · FY2023 · HL
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors$424,794
R01 · FY2023 · CA
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$257,378
U01 · FY2023 · CA · contact PI
Drug Delivery and Molecular Sensing (DDMS)$28,182
P30 · FY2023 · CA · contact PI
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$956,721
U01 · FY2022 · CA · contact PI
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid Chip$836,237
R61 · FY2022 · HL
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$834,158
U01 · FY2022 · HL
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors$424,794
R01 · FY2022 · CA
Drug Delivery and Molecular Sensing (DDMS)$28,182
P30 · FY2022 · CA · contact PI
Dynamic Circadian Regulation of the Blood-Brain Interface in a Human Brain-mimicking Microfluid Chip$852,728
R61 · FY2021 · HL
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$844,766
U01 · FY2021 · HL
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors$448,088
R01 · FY2021 · CA
Drug Delivery and Molecular Sensing (DDMS)$28,182
P30 · FY2021 · CA · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$855,078
U01 · FY2020 · HL
Drug Delivery and Molecular Sensing (DDMS)$28,182
P30 · FY2020 · CA · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$892,860
U01 · FY2019 · HL
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$818,452
U01 · FY2018 · HL
Cryopreservation of functional engineered tissues$285,359
R01 · FY2011 · EB · contact PI
Cryopreservation of functional engineered tissues$297,990
R01 · FY2010 · EB · contact PI
Cryopreservation of functional engineered tissues$193,900
R01 · FY2009 · EB · contact PI
Cryopreservation of functional engineered tissues$143,776
R01 · FY2009 · EB · contact PI
Cryopreservation of functional engineered tissues$288,936
R01 · FY2008 · EB · contact PI